AU7335396A - Membrane-fusible liposome with the use of recombinant sendai virus - Google Patents
Membrane-fusible liposome with the use of recombinant sendai virusInfo
- Publication number
- AU7335396A AU7335396A AU73353/96A AU7335396A AU7335396A AU 7335396 A AU7335396 A AU 7335396A AU 73353/96 A AU73353/96 A AU 73353/96A AU 7335396 A AU7335396 A AU 7335396A AU 7335396 A AU7335396 A AU 7335396A
- Authority
- AU
- Australia
- Prior art keywords
- membrane
- sendai virus
- recombinant sendai
- fusible
- liposome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000711408 Murine respirovirus Species 0.000 title 1
- 239000002502 liposome Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30825295 | 1995-11-01 | ||
JP7-308252 | 1995-11-01 | ||
PCT/JP1996/003070 WO1997016171A1 (en) | 1995-11-01 | 1996-10-22 | Membrane-fusible liposome with the use of recombinant sendai virus |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7335396A true AU7335396A (en) | 1997-05-22 |
Family
ID=17978777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU73353/96A Abandoned AU7335396A (en) | 1995-11-01 | 1996-10-22 | Membrane-fusible liposome with the use of recombinant sendai virus |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP3992200B2 (en) |
AU (1) | AU7335396A (en) |
WO (1) | WO1997016171A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7226786B2 (en) | 1999-05-18 | 2007-06-05 | Dnavec Research Inc. | Envelope gene-deficient Paramyxovirus vector |
ATE399206T1 (en) * | 1999-05-18 | 2008-07-15 | Dnavec Research Inc | RIBONUCLEOPROTEIN COMPLEX FROM PARAMYXOVIRUS |
EP1186667B1 (en) * | 1999-05-18 | 2007-07-18 | Dnavec Research Inc. | Envelope gene-deficient virus vector of paramyxoviridae |
JP4838962B2 (en) * | 1999-11-02 | 2011-12-14 | 株式会社ディナベック研究所 | Recombinant Sendai virus vector for exogenous gene transfer into airway epithelial cells |
JPWO2003092738A1 (en) * | 2002-04-30 | 2005-09-08 | 株式会社ディナベック研究所 | Drug or gene delivery composition with reduced hemagglutinin activity |
JPWO2007049752A1 (en) | 2005-10-28 | 2009-04-30 | ディナベック株式会社 | Gene transfer into airway epithelial stem cells using lentiviral vectors pseudotyped with RNA or DNA virus spike proteins |
EP2738255B1 (en) | 2011-07-29 | 2016-11-23 | Tokushima University | Erap1-derived peptide and use thereof |
EP3889264A4 (en) | 2018-11-30 | 2022-10-12 | Tokushima University | BREAST CANCER THERAPEUTIC WITH BIG3-PHB2 INTERACTION INHIBITING PEPTIDE FROM PHB2 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7007491A (en) * | 1990-02-02 | 1991-08-08 | Schweiz. Serum- & Impfinstitut Bern | Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses |
-
1996
- 1996-10-22 WO PCT/JP1996/003070 patent/WO1997016171A1/en active Application Filing
- 1996-10-22 JP JP51721597A patent/JP3992200B2/en not_active Expired - Fee Related
- 1996-10-22 AU AU73353/96A patent/AU7335396A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP3992200B2 (en) | 2007-10-17 |
WO1997016171A1 (en) | 1997-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU9397098A (en) | Methods and cell line useful for production of recombinant adeno-associated viruses | |
HUP9802217A3 (en) | Recombinant mva virus, and the use thereof | |
AU5801296A (en) | Crosslinkable polypeptide compositions | |
AU4273097A (en) | Headband with dual material construction | |
AU3119895A (en) | Recombinant virus vectors | |
AU5827896A (en) | Inhaler with collapsible chamber | |
AU2705395A (en) | Fas associated proteins | |
AU9222698A (en) | Novel molecules of the tnfr-ligand-related protein family and uses thereof | |
AU4689596A (en) | Anti-inflammatory cd14 peptides | |
AU5320296A (en) | Modified viral envelope polypeptide | |
AU6299594A (en) | Recombinant fowlpox virus s-fpv-043 and uses thereof | |
AU1099597A (en) | Novel xylanases and uses thereof | |
AU7335396A (en) | Membrane-fusible liposome with the use of recombinant sendai virus | |
AUPO026596A0 (en) | Viral peptide | |
AU2131195A (en) | Prophenins - antibiotic peptides | |
AU1991799A (en) | Molecules associated with the human suppressor of fused gene | |
AU5652396A (en) | Glucose-inducible recombinant viral vector | |
AU6715094A (en) | Recombinant vaccine | |
AU3288497A (en) | Mammalian tolloid-like gene and protein | |
AU5550296A (en) | Conotoxin peptides | |
AU5293198A (en) | Promoter of the human endoglin gene and its use | |
AU2168795A (en) | Recombinant Gibberellin DNA and uses thereof | |
AUPM489194A0 (en) | Peptides | |
AU1954995A (en) | Viral replicon | |
AU6087694A (en) | The l-plastin promoter region and its uses |